65,437 trials
Dyslipidemias · Hypercholesterolemia · Familial Hypercholesterolemia
Primary: Effect of Fixed-Dose Combination (FDC) Compared to Placebo on LDL-C — -45.58; 3.03 percent change from baseline — p=<.0001
Traumatic Brain Injury · Chronic Pain · Post Traumatic Stress Disorder
Primary: The Depression Anxiety and Stress Scale (DASS-21) -TOTAL Score — 28.97; 30.77 units on a scale
Head and Neck Cancer
Primary: Adverse Events - Evaluate Safety of a 7-injection Regimen of PepCan. — 23; 0; 0; 1 adverse event
Substance Use Disorders · HIV · Depression
Primary: Change in Mental Health and Substance Use Screening Rates — 2008; 2379 Participants
Opioid Abuse
Primary: Change in Daily Average Number of 5 MME Pill Counts — -3.73; 3.89; 9.8; -4.85 Difference in estimated mean pill counts — p=0
Tobacco Use Disorder
Primary: Spent the Budget on E-cigarettes for Each Condition — 10.64; 14.87; 14.74; 14.65 percentage of spent budget
Chronic Urticaria
Primary: Change From Baseline in the ISS7 at Week 12, TEV-45779 High Dose Compared to XOLAIR High Dose (For European Medicines Agency [EMA] Submission) — -10.92; -10.61 units on…
Hidradenitis Suppurativa (HS)
Primary: Percent Change in Wound Size — 57.2 percentage change in wound size
Low-Grade Gliomas · Malignant Neoplasms, Brain · Soft Tissue Neoplasms
Primary: Best Overall Response Rate (Strata 1 and 2) — 15; 12 Participants
RSV Infection
Primary: Quantitative Reverse Transcription-polymerase Chain Reaction (qRT-PCR): RSV Area Under the Viral Load-time Curve (VL-AUC) — 99.05; 82.28; 657.45 log10 copies/mL*hours…
Multiple Myeloma
Primary: Percentage of Participants With Grade ≥2 Corneal Events Assessed by Keratopathy Visual Acuity (KVA) Scale — 64; 40; 44; 38 Percentage of participants
Yellow Fever
Primary: Peak Neutralizing Antibody Titer — 1.37 Log YF antibody titer
Adenosquamous Carcinoma of the Pancreas
Primary: Proportion of Evaluable Participants Who Experience Clinical Benefit (Disease Control Rate = Complete Response (CR)+Partial Response (PR)+Stable Disease x16 Weeks)…
Bladder Diseases · Interstitial Cystitis
Primary: Global Response Assessment (GRA) — 74; 61; 61; 75 Participants
Substance-Related Disorders
Primary: High Ventilated Cigarette Purchases — 104.22; 29.64; 52.38; 47.41 single unit quantity purchased